| Anti-PlGF inhibits growth of VEGF (R)-inhibitor-resistant tumors without affecting healthy vessels C Fischer, B Jonckx, M Mazzone, S Zacchigna, S Loges, L Pattarini, ... Cell 131 (3), 463-475, 2007 | 941 | 2007 |
| Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction D Vanhoutte, MWM Schellings, M Götte, M Swinnen, V Herias, MK Wild, ... Circulation 115 (4), 475-482, 2007 | 166 | 2007 |
| Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice D Tirziu, E Chorianopoulos, KL Moodie, RT Palac, ZW Zhuang, M Tjwa, ... The Journal of clinical investigation 117 (11), 3188-3197, 2007 | 161 | 2007 |
| Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium X Li, M Tjwa, I Van Hove, B Enholm, E Neven, K Paavonen, M Jeltsch, ... Arteriosclerosis, thrombosis, and vascular biology 28 (9), 1614-1620, 2008 | 154 | 2008 |
| Regulation of endothelin‐1 and transforming growth factor‐β1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans BA Yard, E Chorianopoulos, D Herr, FJ van der Woude Nephrology Dialysis Transplantation 16 (9), 1769-1775, 2001 | 137 | 2001 |
| FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK E Chorianopoulos, T Heger, M Lutz, D Frank, F Bea, HA Katus, N Frey Basic research in cardiology 105, 301-313, 2010 | 135 | 2010 |
| Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial KC Wollert, GP Meyer, J Müller-Ehmsen, C Tschöpe, V Bonarjee, ... European heart journal 38 (39), 2936-2943, 2017 | 114 | 2017 |
| Usefulness of percutaneous aortic valve implantation to improve quality of life in patients> 80 years of age R Bekeredjian, U Krumsdorf, E Chorianopoulos, K Kallenbach, M Karck, ... The American journal of cardiology 106 (12), 1777-1781, 2010 | 113 | 2010 |
| One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip© implantation ST Pleger, M Schulz‐Schönhagen, N Geis, D Mereles, E Chorianopoulos, ... European journal of heart failure 15 (8), 919-927, 2013 | 90 | 2013 |
| Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure E Chorianopoulos, M Rosenberg, C Zugck, J Wolf, HA Katus, N Frey European journal of heart failure 11 (11), 1050-1056, 2009 | 87 | 2009 |
| Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome E Chorianopoulos, K Jarr, H Steen, E Giannitsis, N Frey, HA Katus Atherosclerosis 211 (1), 322-326, 2010 | 78 | 2010 |
| Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients ST Pleger, D Mereles, M Schulz-Schönhagen, U Krumsdorf, ... The American journal of cardiology 108 (10), 1478-1482, 2011 | 64 | 2011 |
| Improvements of procedural results with a new‐generation self‐expanding transfemoral aortic valve prosthesis in comparison to the old‐generation device B Gomes, NA Geis, E Chorianopoulos, B Meder, F Leuschner, HA Katus, ... Journal of interventional cardiology 30 (1), 72-78, 2017 | 61 | 2017 |
| First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome MI MURRAY, N Geis, ST Pleger, K Kallenbach, HA Katus, R Bekeredjian, ... Journal of interventional cardiology 28 (1), 109-116, 2015 | 59 | 2015 |
| NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation NA Geis, C Kiriakou, E Chorianopoulos, L Uhlmann, HA Katus, ... Clinical Research in Cardiology 107, 799-806, 2018 | 56 | 2018 |
| Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve® aortic bioprosthesis E Chorianopoulos, U Krumsdorf, ST Pleger, HA Katus, R Bekeredjian Clinical Research in Cardiology 101, 349-355, 2012 | 55 | 2012 |
| Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis E Chorianopoulos, U Krumsdorf, N Geis, ST Pleger, E Giannitsis, ... Clinical research in cardiology 103, 65-72, 2014 | 50 | 2014 |
| Beneficial effects of prolonged systemic administration of PLGF on late outcome of post‐ischaemic myocardial performance C Roncal, I Buysschaert, EK Chorianopoulos, M Georgiadou, O Meilhac, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 48 | 2008 |
| Feasibility and clinical benefit of a suture-mediated closure device for femoral vein access after percutaneous edge-to-edge mitral valve repair NA Geis, ST Pleger, E Chorianopoulos, OJ Müller, HA Katus, ... EuroIntervention 10 (11), 1346-1353, 2015 | 46 | 2015 |
| Feasibility and safety of vitamin K antagonist monotherapy in atrial fibrillation patients undergoing transcatheter aortic valve implantation. NA Geis, C Kiriakou, E Chorianopoulos, ST Pleger, HA Katus, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2017 | 44 | 2017 |
